首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1357952

人類微生物組市場：按產品類型、用途、適應症、配銷通路和地區

Human Microbiome Market, By Product Type, Application, Disease Indication (Auto Immune Disorder, Clostridium Difficile Infection, Metabolic Disorder, Inflammatory Bowel disorder, Infectious Diseases, & Others), Distribution Channel, & Geography

出版日期: 2023年09月11日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2023 年，全球人類微生物組市場價值 6.179 億美元，預計在預測期內（2023-2030 年）年複合成長率為 24.6%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	6.179 億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	24.60%	2030年市場規模預測	28.845 億美元

人類微生物全球市場佔有率(%)（依產品類型），2023 年

人類微生物組是指存在於人類體內和體外的所有微生物，是構成人類宏基因組的微生物基因組的集合。人類微生物群由 10 兆至 100 兆個共生微生物細胞結構，主要是人類腸道細菌。年齡、營養狀況、生活方式、荷爾蒙變化、遺傳基因和潛在疾病是人體微生物群的主要要素，微生物群的變化或失衡可能導致癌症、腸道炎症，甚至可能導致危及生命的疾病，包括心血管疾病由於抗生素抗藥性而導致的疾病和難以治療的細菌感染疾病。微生物組的作用是促進食物消化、調節免疫系統並產生維生素 K、維生素 B 和維生素 B12 等維生素。根據2022 年8 月發表在《微生物技術雜誌》上的一篇論文，組織免疫反應由微生物組組成控制，每個組織都有獨特的微環境，使其微生物組組成不同。具有不同的微生物組組成，特別是與不同類型的癌症有關，如乳腺癌、結腸癌、腎癌、肺癌和皮膚癌。因此，微生物組產業的主要企業都在關注研究。

市場動態

微生物組產業的主要參與者正在專注於宏基因組學和轉錄組學等新分子技術的研發。營養不良研究和感染疾病的最新進展確立了基於微生物組的策略的潛力，可以解決全球健康中一些最大的挑戰，包括癌症、慢性胃腸道發炎、心血管疾病、焦慮和憂鬱。例如，2023年4月，開發微生物組治療藥物的Ceres Therapeutics公司宣布開發一款給藥VOWSTT的藥物，旨在預防成人在對複發性CDI進行抗生素治療後復發艱難梭菌感染疾病。微生物組療法已獲得美國食品藥物管理局(FDA) 的核准。因此，人類微生物組領域的持續研究和開發為製藥公司開發涉及治療各種罕見疾病的創新藥物和治療方法提供了機會。

本研究的主要特點

本報告詳細分析了全球人類微生物組市場，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率(CAGR)。它揭示了不同細分市場的潛在收入機會，並解釋了市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
該報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球人類微生物組市場的主要企業。
該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
全球人類微生物組市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球人類微生物組市場的各種策略矩陣來促進他們的決策。

公司簡介
- Seres Therapeutics
- BIOMESENSE
- Microbiotica
- Vedanta Biosciences, Inc.
- SECOND GENOME THERAPEUTICS
- Finch Therapeutics Group, Inc
- Enterome
- BiomX
- MaaT Pharma
- Azitra
- Illumina, Inc
- Locus Biosciences, Inc
- Finch Therapeutics Group, Inc
- Rebiotix Inc
- Servatus Ltd
- Microbiome Research Pvt. Ltd
- AOBiome
- Axial Therapeutics, Inc
- Biomica.

第11章章節

參考
調查方法

簡介目錄

Product Code: CMI182

Global human microbiome market is estimated to be valued at US$ 617.9 Mn in 2023, and is expected to exhibit a CAGR of 24.6% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 617.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	24.60%	2030 Value Projection:	US$ 2,884.5 Mn

Global Human Microbiome Market Share (%), By Product Type, 2023

Human microbiome are the full range of microorganisms that are present inside and outside the Humans, It is collection of microbial genomes that contribute to metagenome, of a human. The human micro biota consists of the 10-100 trillion symbiotic microbial cells primarily bacteria in the gut the human. The age, nutrition, lifestyle, hormonal changes, inherited genes, and underlying disease are major determinants of the human microbiome, and any change or in balance in microbiota can cause life threatening illness such as cancer, bowel inflammatory disease, cardiovascular disease, and difficult-to-treat bacterial infections due to antibiotic resistance. Their roles ranges from enabling easy digestion of food, regulation of immune system, and production of vitamins such as Vitamin K, Vitamin B, and Vitamin B12. According to the article published published by journal of microbial biotechnology, published on August 2022, tissue immune responses are regulated by their microbiome composition, and each tissue has their specific microenvironment that makes their microbiome composition different, particularly in the context of different types of cancer, such as breast, colorectal, kidney, lung, and skin. Herein, key players in the microbiome industry are focusing on researches and studies.

Market Dynamics

The key players in the microbiome industry are focusing on researches and development of new molecular technologies such as metagenomics, transcriptomics. Recent advances in malnutrition research and infectious disease have established the potential for microbiome-based strategies to address the biggest challenges in global health including cancer, chronic inflammation in GIT, CVD, anxiety and depression, and others. For instance, in April 2023, Seres Therapeutics, a microbiome therapeutics company that developsbiological drugs, received the U.S. food and Drug Administration approval for it's first orally administered microbiome therapeutic drug named 'VOWSTT' for prevention of recurrence of C. difficile infection in adults following antibacterial treatment for recurrent CDI. Thus, the ongoing research and development in the field of human microbiome offer opportunities for the pharmaceutical companies to develop more innovative drugs or therapies that are involved to treat various range of rare diseases.

Key features of the study:

This report provides an in-depth analysis of the global human microbiomes market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global human microbiomes market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Seres Therapeutics, BIOMESENSE, Microbiotica, Vedanta Biosciences, Inc., SECOND Seres Therapeutics, Biomesense, Microbiotica, Infant Bacterial Therapeutics AB, Vedanta Biosciences, Inc., Second genome therapeutics, 4D Pharma Ferring Inc, Enterome, BiomX, MaaT Pharma, Azitra, Illumina, Inc, Locus Biosciences, Inc, Finch Therapeutics Group, Inc, Rebiotix Inc, Servatus Ltd, Microbiome Research Pvt. Ltd, AOBiome, Axial Therapeutics, Inc, Biomica
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global human microbiomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human microbiomes market

Detailed Segmentation:

Global Human Microbiomes Market, By Product Type:
- Food
- Probiotics
- Prebiotics
- Medical Food Supplements
- Microbiome Drugs
- Fecal Microbiota Transplant
- Others (Symbiotic, Antibiotics, etc.)
Global Human Microbiome Market, By Application:
- Therapeutics
- Diagnostics
- Nutrition and Deities
- Others (Cosmetics, Animal health etc. )
Global Human Microbiome Market, By Disease Indication:
- Auto Immune Disorder
- Clostridium Difficile Infection
- Metabolic Disorder
- Inflammatory Bowel disorder
- Infectious Diseases
- Others (Cancer, Rare Diseases)
Global Human Microbiome Market, By Disribution Channel:
- Hospital
- Retail Pharmacies
- Online Pharmacies
Global Human Microbiome Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Seres Therapeutics
- Biomesense
- Microbiotica
- Infant Bacterial Therapeutics AB
- Vedanta Biosciences, Inc.
- SECOND GENOME THERAPEUTICS
- Finch Therapeutics Group, Inc
- Enterome
- BiomX
- MaaT Pharma
- Azitra
- Illumina, Inc
- Locus Biosciences, Inc
- Finch Therapeutics Group, Inc
- Rebiotix Inc
- Servatus Ltd
- Microbiome Research Pvt. Ltd
- AOBiome
- Axial Therapeutics, Inc
- Biomica

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Disease Indication
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Human Microbiome Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Human Microbiome Market, By Product Type, 2018- 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Food
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Probiotics
- Prebiotics
- Medical Food Supplements
Microbiome Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Fecal Microbiota Transplant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others (Symbiotic, Antibiotics, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Human Microbiome Market, By Application, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Nutrition and Deities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

7. Global Human Microbiome Market, By Disease Indication, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Auto Immune Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Clostridium Difficile Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Metabolic Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Inflammatory Bowel Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others (Cancer, Rare Diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

8. Global Human Microbiome Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

9. Global Human Microbiome Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- U.S.
- Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa

10. Competitive Landscape

Company Profiles
- Seres Therapeutics
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- BIOMESENSE
- Microbiotica
- Vedanta Biosciences, Inc.
- SECOND GENOME THERAPEUTICS
- Finch Therapeutics Group, Inc
- Enterome
- BiomX
- MaaT Pharma
- Azitra
- Illumina, Inc
- Locus Biosciences, Inc
- Finch Therapeutics Group, Inc
- Rebiotix Inc
- Servatus Ltd
- Microbiome Research Pvt. Ltd
- AOBiome
- Axial Therapeutics, Inc
- Biomica.